Amarin Corp Plc (AMRN)

[nutsyprofessor]

Mr. Jesse, I guess the problem here is that we are not communicating effectively. First of all, your Jupiter (Crestor) trial was going after a separate (specific) and different issue than Vascepa.

The Crestor (Jupiter) trial was focused on inflammation caused by OTHER diseases, that's right OTHER diseases! Namely, and as you mentioned it, specifically looking for individuals with high levels of C-reactive protein (CRP), an inflammation biomarker.

This has NOTHING, repeat NOTHING to do with elevated triglycerides/lipids, which ALSO causes inflammation due to the body's natural response!!!

That is exactly why they used individuals with normal/low LDL levels i.e. TO RULE OUT THE KNOWN FACT THAT HIGH LIPID ACCUMULATION ON VESSEL WALLS CAUSES INFLAMMATION AS WELL! LOL

This is a classic case of not seeing the forest through the trees. You see sir, the problem is that you are so HUNG UP on convincing yourself that elevated C-reactive protein (inflammation) is caused by some mysterious and unknown disease that you fail to realize that there are many things that can cause inflammation. The fact remains that if you friggin PLUG up your vessels with lipids (fatty acids) you WILL experience increased CVD...PERIOD! Therefore, if you LOWER the lipid accumulation in the blood vessel walls, you will lower the incidence of CVD. Now guess what Vascepa's purpose is?

jesse you are totally and completely off track on the vascepa conversation. I believe it is you that needs to listen more and not be so closed minded.

GL to you man.